Furosemide as Supportive Therapy for COVID-19 Respiratory Failure

NCT04588792 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

40

Enrollment

OTHER

Sponsor class

Stopped Lack of recruitment due to decline in critically ill Covid-19 patients

Conditions

Covid19
Respiratory Failure

Interventions

DRUG: Nebulized Furosemide
DRUG: Nebulized Saline

Sponsor

Dr. John Muscedere

Collaborators

[object Object]